Summary
- Current Price
- As of today, IPSC price is $2.56, unchanged in the most recent trading session on
- Current Price All-Time High
- IPSC price is currently -92.22% below its historical high of $32.90 set on
- Market Cap
- IPSC current market cap is $224M, up +297.02% over the past 365 days
- PE Ratio
- IPSC PE ratio is unknown
- Revenue
- IPSC current annual revenue is $6.59M, up +194.81% year-over-year
- Next Earnings
- The next earnings release for IPSC is on
Profile
| Metric | Value |
|---|---|
| Full Name | Century Therapeutics, Inc. |
| Ticker | NASDAQ: IPSC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | centurytx.com |
| Employees | 140 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.56 | ||
| Price, 1D Change | 0.00% | |
| $224M | ||
| - | ||
| - | ||
| 1.29 | ||
| $7M | ||
| Revenue, 1Y Change | +194.81% | |
| -$1.61 | ||
| EPS, 1Y Change | +30.16% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.61 | ||
| EPS Estimate | -$0.13 | |
| EPS Est. Change | +91.92% | |
| $6.59M | ||
| Revenue Estimate | $109.17M | |
| Revenue Est. Change | +1,556.88% | |
| $2.56 | ||
| Price Target | - | $3.00 |
| Price Tgt. Change | - | +17.19% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.09 | -$2.30 | -10.25% | |
| -$1.63 | -$1.61 | +0.97% | |
| -$0.13 | N/A | +91.92% | |
| -$0.90 | N/A | +44.28% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.82M | $2.24M | -41.49% | |
| $3.35M | $6.59M | +96.87% | |
| $109.17M | N/A | +1,556.88% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +290.84% | ||
| -49.90% | ||
| +297.02% | ||
| -26.00% | ||
| +194.81% | ||
| +100.00% | ||
| +30.16% | ||
| +7.63% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.56 | ||
| $0.89 | ||
| SMA 200 vs Price | -65.30% | |
| $1.88 | ||
| SMA 50 vs Price | -26.49% | |
| 1.29 | ||
| $0.20 | ||
| 69.66 | ||
| 47.82% | ||
| 98.21% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $6.59M | ||
| -$1.61 | ||
| -$6.72M | ||
| -101.91% | ||
| -$133.81M | ||
| -2,037.81% | ||
| -$126.57M | ||
| -1,920.87% | ||
| -$111.47M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.33 | ||
| 1.50 | ||
| 1.50 | ||
| - | ||
| - | ||
| -3.33 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.97 | ||
| 1.27 | ||
| -13.88 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $161.36M | ||
| $58.44M | ||
| $353.22M | ||
| $194.05M | ||
| $191.85M | ||
| $129.78M | ||
| $53.83M | ||
| $4.87M | ||
| $3.08M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $140.40M | ||
| $140.40M | ||
| $13.30M | ||
| $33.16M | ||
| $13.30M | ||
| $0.00 | ||
| $1.79M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$110.14M | ||
| $47.48M | ||
| $74.56M | ||
| $154.00K | ||
| -$110.29M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| Leerink Partners | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Chardan Capital | → | |
| Guggenheim | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → |
Analyst sentiment
Institutional ownership
Screeners with IPSC
FAQ
What is the ticker symbol for Century Therapeutics, Inc.?
The ticker symbol for Century Therapeutics, Inc. is NASDAQ:IPSC
Does Century Therapeutics, Inc. pay dividends?
No, Century Therapeutics, Inc. does not pay dividends
What sector is Century Therapeutics, Inc. in?
Century Therapeutics, Inc. is in the Healthcare sector
What industry is Century Therapeutics, Inc. in?
Century Therapeutics, Inc. is in the Biotechnology industry
What country is Century Therapeutics, Inc. based in?
Century Therapeutics, Inc. is headquartered in United States
When did Century Therapeutics, Inc. go public?
Century Therapeutics, Inc. initial public offering (IPO) was on June 18, 2021
Is Century Therapeutics, Inc. in the S&P 500?
No, Century Therapeutics, Inc. is not included in the S&P 500 index
Is Century Therapeutics, Inc. in the NASDAQ 100?
No, Century Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Century Therapeutics, Inc. in the Dow Jones?
No, Century Therapeutics, Inc. is not included in the Dow Jones index
When was Century Therapeutics, Inc. last earnings report?
Century Therapeutics, Inc.'s most recent earnings report was on November 13, 2025
When does Century Therapeutics, Inc. report earnings?
The next expected earnings date for Century Therapeutics, Inc. is March 19, 2026
Data Sources & References
- IPSC Official Website www.centurytx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1850119/000110465925110851/0001104659-25-110851-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1850119/000155837025003299/0001558370-25-003299-index.htm
- IPSC Profile on Yahoo Finance finance.yahoo.com/quote/IPSC
- IPSC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ipsc